Partha S. Ray

1.9k total citations
30 papers, 1.3k citations indexed

About

Partha S. Ray is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Partha S. Ray has authored 30 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in Partha S. Ray's work include Breast Cancer Treatment Studies (5 papers), Pneumonia and Respiratory Infections (4 papers) and Emergency and Acute Care Studies (4 papers). Partha S. Ray is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Pneumonia and Respiratory Infections (4 papers) and Emergency and Acute Care Studies (4 papers). Partha S. Ray collaborates with scholars based in United States, United Kingdom and India. Partha S. Ray's co-authors include Dipak K. Das, Gautam Maulik, A Bertelli, A Bertelli, Gerald A. Cordis, Nilanjana Maulik, Richard M. Engelman, A Bertelli, G. Maulik and A. Bertelli and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Partha S. Ray

30 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Partha S. Ray United States 15 426 334 316 216 214 30 1.3k
Róbert Halmosi Hungary 19 421 1.0× 225 0.7× 314 1.0× 114 0.5× 246 1.1× 42 1.3k
Subhendu Mukherjee United States 23 701 1.6× 165 0.5× 360 1.1× 136 0.6× 123 0.6× 56 1.7k
Livia Barenghi Italy 16 325 0.8× 93 0.3× 341 1.1× 156 0.7× 50 0.2× 39 1.2k
Dheyauldeen Shabeeb Iran 25 644 1.5× 103 0.3× 95 0.3× 43 0.2× 290 1.4× 51 1.7k
Zheng Yang China 28 814 1.9× 189 0.6× 79 0.3× 119 0.6× 144 0.7× 51 1.7k
Guy Faust United Kingdom 8 341 0.8× 125 0.4× 568 1.8× 115 0.5× 242 1.1× 30 1.0k
Paolo Nassi Italy 23 846 2.0× 160 0.5× 123 0.4× 70 0.3× 146 0.7× 76 1.7k
Éva Szabó Hungary 23 705 1.7× 281 0.8× 78 0.2× 52 0.2× 930 4.3× 37 2.3k
Dongye Li China 29 800 1.9× 283 0.8× 40 0.1× 177 0.8× 94 0.4× 103 2.2k

Countries citing papers authored by Partha S. Ray

Since Specialization
Citations

This map shows the geographic impact of Partha S. Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Partha S. Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Partha S. Ray more than expected).

Fields of papers citing papers by Partha S. Ray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Partha S. Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Partha S. Ray. The network helps show where Partha S. Ray may publish in the future.

Co-authorship network of co-authors of Partha S. Ray

This figure shows the co-authorship network connecting the top 25 collaborators of Partha S. Ray. A scholar is included among the top collaborators of Partha S. Ray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Partha S. Ray. Partha S. Ray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taylor, Clive R., Carlos H. Barrios, Manuel Ruíz-Borrego, et al.. (2024). Non-basal subtype defined by FOXC1 expression as an independent predictor of capecitabine efficacy in the triple negative breast cancer GEICAM/2003-11_CIBOMA/2004-01 trial.. Journal of Clinical Oncology. 42(16_suppl). 516–516. 1 indexed citations
2.
Mukherjee, Aparna, Kana Ram Jat, Rakesh Lodha, et al.. (2022). Feasibility of establishing acute respiratory infection treatment units (ATU) for improvement of care of children with acute respiratory infection. BMC Pediatrics. 22(1). 189–189. 1 indexed citations
3.
Srivastava, Abhishek, et al.. (2021). Tele-Neurorehabilitation During the COVID-19 Pandemic: Implications for Practice in Low- and Middle-Income Countries. Frontiers in Neurology. 12. 667925–667925. 13 indexed citations
4.
Ray, Tania, et al.. (2020). Superior breast cancer metastasis risk stratification using an epithelial-mesenchymal-amoeboid transition gene signature. Breast Cancer Research. 22(1). 74–74. 15 indexed citations
5.
6.
Das, Rashmi Ranjan, et al.. (2020). Metabolic Syndrome and Insulin Resistance in Schoolchildren From a Developing Country. Frontiers in Nutrition. 7. 31–31. 15 indexed citations
7.
Nolan, Ryan M., Steven G. Adie, Marina Marjanović, et al.. (2016). Intraoperative optical coherence tomography for assessing human lymph nodes for metastatic cancer. BMC Cancer. 16(1). 144–144. 48 indexed citations
8.
Swaminathan, Mahesh, Tor Jensen, Tania Ray, et al.. (2016). FOXC1 Expression in Acute Myeloid Leukemia: Potential Predictor of Disease Relapse and/or Refractory Disease. Blood. 128(22). 5260–5260. 4 indexed citations
9.
Nolan, Ryan M., Nathan D. Shemonski, Steven G. Adie, et al.. (2015). Real-time Imaging of the Resection Bed Using a Handheld Probe to Reduce Incidence of Microscopic Positive Margins in Cancer Surgery. Cancer Research. 75(18). 3706–3712. 110 indexed citations
10.
Jensen, Tor, Tania Ray, Jinhua Wang, et al.. (2015). Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay. JNCI Journal of the National Cancer Institute. 107(8). 46 indexed citations
11.
Bagaria, Sanjay P., Partha S. Ray, Richard W. Joseph, et al.. (2013). Ultrathin primary is a marker for worse prognosis in lymph node–positive cutaneous melanoma. Cancer. 119(10). 1860–1867. 7 indexed citations
12.
Wasif, Nabil, Sanjay P. Bagaria, Partha S. Ray, & Donald L. Morton. (2011). Does metastasectomy improve survival in patients with stage IV melanoma? a cancer registry analysis of outcomes. Journal of Surgical Oncology. 104(2). 111–115. 75 indexed citations
13.
Bagaria, Sanjay P., Partha S. Ray, Jinhua Wang, et al.. (2011). Prognostic Value of Basal Phenotype in HER2-overexpressing Breast Cancer. Annals of Surgical Oncology. 19(3). 935–940. 26 indexed citations
14.
Bagaria, Sanjay P., et al.. (2011). The Florid Subtype of Lobular Carcinoma In Situ: Marker or Precursor for Invasive Lobular Carcinoma?. Annals of Surgical Oncology. 18(7). 1845–1851. 25 indexed citations
15.
Ray, Partha S., et al.. (2010). Invasive IPMN and MCN: Same Organ, Sifferent Outcomes?. Annals of Surgical Oncology. 18(2). 345–351. 14 indexed citations
16.
Emsley, Hedley, et al.. (2008). Pontine infarction due to intracranial venous thrombosis. Practical Neurology. 8(4). 254–255. 1 indexed citations
17.
Larner, A. J., Partha S. Ray, & Mark Doran. (2007). The R269H mutation in presenilin-1 presenting as late-onset autosomal dominant Alzheimer's disease. Journal of the Neurological Sciences. 252(2). 173–176. 22 indexed citations
18.
Sato, Motoaki, Partha S. Ray, Gautam Maulik, et al.. (2000). Myocardial Protection with Red Wine Extract. Journal of Cardiovascular Pharmacology. 35(2). 263–268. 93 indexed citations
19.
Ray, Partha S., Gautam Maulik, Gerald A. Cordis, et al.. (1999). The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radical Biology and Medicine. 27(1-2). 160–169. 290 indexed citations
20.
Maulik, Gautam, et al.. (1999). Cardioprotective Effects of Grape Seed Proanthocyanidin Against Ischemic Reperfusion Injury. Journal of Molecular and Cellular Cardiology. 31(6). 1289–1297. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026